Dalargin and oxidative stress in severe combined trauma: a prospective clinical study
Comparison in people · 2023
- What was studied
- 104 severe combined-trauma patients
- Main finding
- Among 104 patients (38 Dalargin, 66 controls), the authors reported lower oxidative-stress markers and fewer ARDS/acute kidney injury events. Mortality and infectious complications were comparable; antioxidant activity remained below normal. Hospitalization was shorter among survivors receiving Dalargin.
Mortality · 8/38 (21.1%) versus 17/66 (25.8%) · p=0.6412; nonsignificant
Reported findings and study design
Reported findings
ARDS and kidney injury were less frequent; mortality, infection and overall ICU stay did not differ significantly.
104 trauma patients: 38 Dalargin, 66 controls; allocation safeguards unverified.
Population or model 104 severe combined-trauma patients
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Mortality | 8/38 (21.1%) versus 17/66 (25.8%) | p=0.6412; nonsignificant |
| ARDS | 2/38 (5.3%) versus 14/66 (21.2%) | p=0.0457 |
| Acute kidney injury | 1/38 (2.6%) versus 13/66 (19.7%) | p=0.0286 |
| Overall ICU stay | 12.5 [6.0–34.5] versus 15.0 [5.0–34.0] days | Median [IQR]; narrative prints 36.5 for the first upper quartile · p=0.8635; nonsignificant |
| ICU stay among survivors | 29.0 [12.0–36.0] versus 36.5 [21.8–54.0] days | Survivor subset; selection may bias comparison · p=0.0015 |
| Infection and antioxidant activity | Infections comparable; antioxidant activity remained below normal |
Dalargin versus standard care throughout. Unequal groups and unverified assignment prevent causal inference. No survival benefit established.
Source for these results ↗ · Reviewed 2026-11-06
Study limitations and source details
Study limitations
- Unequal groups; randomized allocation and blinding not established in this appraisal.
- Biomarker changes do not prove improved survival; survivor-only length of stay requires caution.
Source details
Original publisher HTML, selected clinical outcomes and Table 2 checked. Overall and survivor-only ICU stay distinguished; narrative/table upper-quartile discrepancy retained.
Selected text reviewed
Sources checked
Citation
V. V. Antonova, A. K. Evseev, I. V. Goroncharovskaya, A. Yu. Ryzhkov, O. A. Grebenchikov, A. K. Shabanov. Dalargin and oxidative stress in severe combined trauma: a prospective clinical study Annals of Critical Care. 2023;(4):185–196
Study source ↗ · DOI 10.21320/1818-474X-2023-4-185-196 · Bibliography entry · Link to this summary